Global Type-2 Diabetes Market Analysis, 2020

By Drug Type (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Alpha-glucosidase Inhibitors, Biguanides, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2), Sulfonylureas, Other (Thiazolidinediones, Meglitinides, Glitazones, etc.), By Gender Type (Male, Female), By Age Group (Upto 19 Years, 20 – 65 Year, Above 65), By Region (North America, South America, Europe, Middle East & Africa, Asia-Pacific), By Country (U.S., Canada, Mexico, Brazil, Argentina, U.K., Germany, France, Italy, Spain, UAE, Saudi Arabia, South Africa, Chi

  • Healthcare
  • Jun 2020
  • 178
  • HC22021

Why Choose Us

  • Free 20% Customization
  • Pool of Best Industry Minds
  • Knowledge Partner to Fortune Brands
  • Real-Time Client Support
  • Comprehensive Insights on Niche Areas